| Date Filed | Type | Description |
| 10/04/2023 |
4
| Snisarenko John (Director) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Granted 50,000 options to buy
@ $2.99, valued at
$149.5k
|
|
| 01/06/2023 |
4
| Snisarenko John (Director) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Granted 6,000 options to buy
@ $2.7183, valued at
$16.3k
|
|
| 01/11/2022 |
4
| Snisarenko John (Chief Commercial Officer) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Granted 12,100 shares
@ $0
Granted 54,500 options to buy
@ $16, valued at
$872k
|
|
| 11/04/2021 |
4
| Snisarenko John (Director) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Granted 6,000 options to buy
@ $4.05, valued at
$24.3k
|
|
| 09/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2020 |
4
| Snisarenko John (Chief Commercial Officer) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Bought 4,000 shares
@ $25.97, valued at
$103.9k
|
|
| 06/22/2020 |
4
| Snisarenko John (Director) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Granted 3,333 options to buy
@ $6.7, valued at
$22.3k
|
|
| 02/05/2020 |
4
| Snisarenko John (Chief Commercial Officer) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Granted 72,648 options to buy
@ $32.65, valued at
$2.4M
|
|
| 11/25/2019 |
4
| Snisarenko John (Director) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Bought 10,000 shares
@ $4.95, valued at
$49.5k
|
|
| 11/05/2019 |
4
| Snisarenko John (Chief Commercial Officer) has filed a Form 4 on Oyster Point Pharma, Inc.|
Txns:
| Bought 3,000 shares
@ $16, valued at
$48k
|
|
| 10/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/22/2019 |
4
| Snisarenko John (Director) has filed a Form 4 on ALIMERA SCIENCES INC|
Txns:
| Granted 46,150 options to buy
@ $0.865, valued at
$39.9k
|
|
| 07/22/2019 |
3
| Snisarenko John (Director) has filed a Form 3 on ALIMERA SCIENCES INC |